Overview of age-variations
Age group comparisons |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
17474139 |
Age 36.6 ± 5.5, Gender ⚥ |
220.3 (mmol/mol ) |
H-NMR |
urine |
17474139 |
Age 54.5 ± 7.6, Gender ⚥ |
235.0 (mmol/mol ) |
H-NMR |
urine |
24457528 |
Age 100.7 ± 2.1, Gender ⚥ |
1.01 (mean of regulated metabolite) |
H-NMR |
serum |
24457528 |
Age 70 ± 6, Gender ⚥ |
0.82 (mean of regulated metabolite) |
H-NMR |
serum |
24457528 |
Age 100.7 ± 2.1, Gender ♀ |
1.0 (mean of regulated metabolite) |
H-NMR |
serum |
24457528 |
Age 70 ± 6, Gender ♀ |
0.81 (mean of regulated metabolite) |
H-NMR |
serum |
24457528 |
Age 100.7 ± 2.1, Gender ♂ |
1.01 (mean of regulated metabolite) |
H-NMR |
serum |
24457528 |
Age 70 ± 6, Gender ♂ |
0.83 (mean of regulated metabolite) |
H-NMR |
serum |
27374292 |
Age [25–35] (median=32), Gender ♂ (Japanese) |
0.84335 (average level of metabolite) |
UHPLC-MS/MS Negative mode |
serum |
27374292 |
Age [55–64] (median=60), Gender ♂ (Japanese) |
1.119249 (average level of metabolite) |
UHPLC-MS/MS Negative mode |
serum |
Linear regression |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
23838602 |
Age [17–85], Gender ⚥ |
0.019 (β) |
UHPLC/MS/MS |
serum and plasma |
23838602 |
Age [17–85], Gender ⚥ |
3.03 (β) |
UHPLC/MS/MS |
serum and plasma |
23838602 |
Age [17–85], Gender ⚥ |
2.84 (β) |
UHPLC/MS/MS |
serum and plasma |
23838602 |
Age [17–85], Gender ⚥ |
1.88 (β) |
UHPLC/MS/MS |
serum and plasma |
log2 ratio/log2(FC) |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
29090929 |
Age 42 ± 12, Gender ♀ |
-0.099 (log2 ratio) |
NMR |
blood |
29090929 |
Age 41 ± 12, Gender ♂ |
-0.092 (log2 ratio) |
NMR |
blood |